449
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Pre-clinical evaluation of the mechanical properties of a low-stiffness cement-injectable hip stem

, , , &
Pages 681-691 | Received 05 Sep 2017, Accepted 16 Oct 2017, Published online: 07 Nov 2017
 

Abstract

In total hip arthroplasty (THA), the femoral stem can be fixed with or without bone cement. Cementless stem fixation is recommended for young and active patients as it eliminates the risk of loss of fixation at the bone–cement and cement–implant interfaces. Cementless fixation, however, suffers from a relatively high early revision rate. In the current research, a novel low-stiffness hip stem was designed, fabricated and tested. The stem design provided the option to inject biodegradable bone cement that could enhance initial stem stability. The stem was made of Ti6Al4V alloy. The proximal portion of the stem was porous, with cubic cells. The stem was fabricated using electron beam melting (EBM) technology and tested in compression and bending. Finite-element analysis was used to evaluate stem performance under a dynamic load representing a stair descending cycle and compare it to the performance of a solid stem with similar geometry. The von Mises stresses and maximum principal strains generated within the bone increased after porous stem insertion compared to solid stem insertion. The low-modulus stem tested in this study has acceptable mechanical properties and generates strain patterns in bone that appear compatible with clinical use.

Acknowledgements

The first author received support from the Mission Department of the Ministry of Higher Education (MoHE) in Egypt and Egypt-Japan University of Science and Technology (E-JUST). Manufacturing and testing facilities were generously provided by the Center for Additive Manufacturing and Logistics (CAMAL) in the Edward P. Fitts Department of Industrial and Systems Engineering, North Carolina State University, USA.

Disclosure statement

No potential conflict of interest was reported by the authors.

Clinical trials

None performed.

Ethical approval

Not required.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.